# Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

> **NCT06410248** · PHASE1 · RECRUITING · sponsor: **Northwestern University** · enrollment: 30 (estimated)

## Conditions studied

- Recurrent Glioblastoma, IDH-Wildtype
- Recurrent WHO Grade 2 Glioma
- Recurrent WHO Grade 3 Glioma
- Recurrent WHO Grade 4 Glioma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Magnetic Resonance Imaging
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Resection
- **DRUG:** Temozolomide
- **DRUG:** Triapine

## Key facts

- **NCT ID:** NCT06410248
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-23
- **Primary completion:** 2029-05-12
- **Final completion:** 2030-05-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06410248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06410248, "Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06410248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*